Abstract
Background: Dysregulated pathway identification is an important task which can gain insight into the underlying biological processes of disease. Current pathway-identification methods focus on a set of co-expression genes and single pathways and ignore the correlation between genes and pathways.
Objective: This study takes into account the internal correlations not only between genes but also pathways to explore the underlying dysregulated pathways of Alzheimer's disease (AD), the most common form of dementia.
Methods: In order to find the significantly differential genes for AD, mutual information (MI) is used to measure interdependencies between genes other than expression valves. Then, by integrating the topology information from KEGG, the significant pathways involved in the feature genes are identified. Next, the distance correlation (DC) is applied to measure the pairwise pathway crosstalks since DC has the advantage of detecting nonlinear correlations when compared to Pearson correlation. Finally, the pathway pairs with significantly different correlations between normal and AD samples are known as dysregulated pathways.
Results: We identified 33 dysregulated pathway pairs related to AD in which the crosstalks score calculated by DC greatly changed from normal to AD samples. The molecular biology analysis demonstrated that many dysregulated pathways related to AD pathogenesis have been discovered successfully by the internal correlation detection.
Conclusion: Our studies on the identification of the dysregulated pathways in the development and deterioration of AD will help to find new effective target genes which are closely related to the pathogenesis of AD and provide important theoretical guidance for drug design.
Keywords: Dysregulated pathway identification, internal correlation, Alzheimer's disease, mutual information, pathway crosstalk, distance correlation.
Combinatorial Chemistry & High Throughput Screening
Title:Dysregulated Pathway Identification of Alzheimer's Disease Based on Internal Correlation Analysis of Genes and Pathways
Volume: 20 Issue: 10
Author(s): Wei Kong*, Xiaoyang Mou, Benteng Di, Jin Deng, Ruxing Zhong and Shuaiqun Wang
Affiliation:
- College of Information Engineering, Shanghai Maritime University, Shanghai 201306,China
Keywords: Dysregulated pathway identification, internal correlation, Alzheimer's disease, mutual information, pathway crosstalk, distance correlation.
Abstract: Background: Dysregulated pathway identification is an important task which can gain insight into the underlying biological processes of disease. Current pathway-identification methods focus on a set of co-expression genes and single pathways and ignore the correlation between genes and pathways.
Objective: This study takes into account the internal correlations not only between genes but also pathways to explore the underlying dysregulated pathways of Alzheimer's disease (AD), the most common form of dementia.
Methods: In order to find the significantly differential genes for AD, mutual information (MI) is used to measure interdependencies between genes other than expression valves. Then, by integrating the topology information from KEGG, the significant pathways involved in the feature genes are identified. Next, the distance correlation (DC) is applied to measure the pairwise pathway crosstalks since DC has the advantage of detecting nonlinear correlations when compared to Pearson correlation. Finally, the pathway pairs with significantly different correlations between normal and AD samples are known as dysregulated pathways.
Results: We identified 33 dysregulated pathway pairs related to AD in which the crosstalks score calculated by DC greatly changed from normal to AD samples. The molecular biology analysis demonstrated that many dysregulated pathways related to AD pathogenesis have been discovered successfully by the internal correlation detection.
Conclusion: Our studies on the identification of the dysregulated pathways in the development and deterioration of AD will help to find new effective target genes which are closely related to the pathogenesis of AD and provide important theoretical guidance for drug design.
Export Options
About this article
Cite this article as:
Kong Wei *, Mou Xiaoyang , Di Benteng, Deng Jin , Zhong Ruxing and Wang Shuaiqun, Dysregulated Pathway Identification of Alzheimer's Disease Based on Internal Correlation Analysis of Genes and Pathways, Combinatorial Chemistry & High Throughput Screening 2017; 20 (10) . https://dx.doi.org/10.2174/1386207320666171121112235
DOI https://dx.doi.org/10.2174/1386207320666171121112235 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Astroglial Connexins as a Therapeutic Target for Alzheimer's Disease
Current Pharmaceutical Design Antithrombin, an Important Inhibitor in Blood Clots
Current Topics in Medicinal Chemistry Astrocyte`s RAGE: More Than Just a Question of Mood
Central Nervous System Agents in Medicinal Chemistry Connections Between Herpes Simplex Virus Type 1 and Alzheimer's Disease Pathogenesis
Current Alzheimer Research A Biomarker Combining Imaging and Neuropsychological Assessment for Tracking Early Alzheimer's Disease in Clinical Trials
Current Alzheimer Research Data Tagging in Medical Images: A Survey of the State-of-Art
Current Medical Imaging New Treatments for COPD in the Elderly
Current Pharmaceutical Design The Retrogenesis Model in Alzheimer’s Disease: Evidence and Pract ical Applications
Current Psychiatry Reviews Reactive Oxygen Species and Antioxidants in the Pathophysiology of Cardiovascular Disease: Does the Actual Knowledge Justify a Clinical Approach?
Current Vascular Pharmacology A Series of Novel Neuroprotective Blood Brain Barrier Penetrating Flavonoid Drugs to Treat Acute Ischemic Stroke
Current Pharmaceutical Design Differential Expression of Ribosomal Genes in Brain and Blood of Alzheimer’s Disease Patients
Current Alzheimer Research Mood, Memory and Movement: An Age-Related Neurodegenerative Complex?
Current Aging Science Focusing on the Interactions between the GABAergic System and Neurosteroids in Neurodevelopmental Disorders
Current Pharmaceutical Design MAPKs as Mediators of Cell Fate Determination: an Approach to Neurodegenerative Diseases
Current Medicinal Chemistry Hybrid Molecules Incorporating Natural Products: Applications in Cancer Therapy, Neurodegenerative Disorders and Beyond
Current Medicinal Chemistry On the Pathogenesis and Neuroprotective Treatment of Parkinson Disease: What have we Learned from the Genetic Forms of this Disease?
Current Medicinal Chemistry Purinergic Signalling and Endothelium
Current Vascular Pharmacology Diabetic CVD – Focus on Vitamin D
Cardiovascular & Hematological Agents in Medicinal Chemistry Visualization of Brain Amyloid and Microglial Activation in Mouse Models of Alzheimers Disease
Current Alzheimer Research Nanotechnology Advances in Brain Tumors: The State of the Art
Recent Patents on Anti-Cancer Drug Discovery